Literature DB >> 2419036

The human tumor cloning assay in cancer research and therapy: a review with clinical correlations.

A R Hanauske, U Hanauske, D D Von Hoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2419036     DOI： 10.1016/s0147-0272(85)80026-x

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN： 0147-0272            Impact factor:   3.187


× No keyword cloud information.
  10 in total

1.  Efficacy of 5'-nor-anhydrovinblastine (vinorelbine), against freshly explanted clonogenic human tumor cells in vitro.

Authors:  I Djuanda; H Depenbrock; R Peter; T Block; G Pohlmann; J Rastetter; A R Hanauske
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

2.  Activity of gemcitabine in a human tumor cloning assay as a basis for clinical trials with gemcitabine. San Antonio Drug Development Team.

Authors:  D D Von Hoff
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

3.  Correlations of mRNA expression and in vitro chemosensitivity to enzastaurin in freshly explanted human tumor cells.

Authors:  Axel-Rainer Hanauske; Ulrike Eismann; Olaf Oberschmidt; Heike Pospisil; Hartmut M Hanauske-Abel; Johannes Blatter; Doreen Ma; Victor Chen; Michael Lahn
Journal:  Invest New Drugs       Date:  2007-11-14       Impact factor: 3.850

4.  Lack of effects of recombinant human interleukin-4 on in vitro colony formation of freshly explanted human tumor cells.

Authors:  A R Hanauske; D Degen; M H Marshall; P P Trotta; D D Von Hoff
Journal:  Invest New Drugs       Date:  1992-11       Impact factor: 3.850

5.  Investigation of the comparative effects of 2-chlorodeoxyadenosine on tumor colony forming units in vitro.

Authors:  H Depenbrock; M Wenger; R Peter; C Fellbaum; T Block; J Rastetter; A R Hanauske
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

6.  Adenocarcinoma of unknown primary: retrospective analysis of chemosensitivity of 313 freshly explanted tumors in a tumor cloning system.

Authors:  A R Hanauske; G M Clark; D D Von Hoff
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

7.  Doxorubicin Promotes Migration and Invasion of Breast Cancer Cells through the Upregulation of the RhoA/MLC Pathway.

Authors:  Chien-Liang Liu; Ming-Jen Chen; Jiunn-Chang Lin; Chi-Hsin Lin; Wen-Chien Huang; Shih-Ping Cheng; Shan-Na Chen; Yuan-Ching Chang
Journal:  J Breast Cancer       Date:  2019-04-22       Impact factor: 3.588

8.  Antitumor activity of enzastaurin (LY317615.HCl) against human cancer cell lines and freshly explanted tumors investigated in in-vitro [corrected] soft-agar cloning experiments.

Authors:  Axel-Rainer Hanauske; Olaf Oberschmidt; Hartmut Hanauske-Abel; Michael M Lahn; Ulrike Eismann
Journal:  Invest New Drugs       Date:  2007-03-09       Impact factor: 3.651

9.  Predictive chemosensitivity testing in malignant melanoma: reliable methodology--ineffective drugs.

Authors:  K M Tveit; S Gundersen; J Høie; A Pihl
Journal:  Br J Cancer       Date:  1988-12       Impact factor: 7.640

10.  Combined effect of papuamine and doxorubicin in human breast cancer MCF-7 cells.

Authors:  Syu-Ichi Kanno; Shin Yomogida; Ayako Tomizawa; Hiroyuki Yamazaki; Kazuyo Ukai; Remy E P Mangindaan; Michio Namikoshi; Masaaki Ishikawa
Journal:  Oncol Lett       Date:  2014-06-03       Impact factor: 2.967
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.